Transcriptomics

Dataset Information

0

PMP22 antisense oligonucleotides reverse clinical, pathological, and molecular features of Charcot-Marie-Tooth disease type 1A

ABSTRACT: RNA sequencing data from sciatic nerves of C22 and wildtype littermates

ORGANISM(S): Mus musculus

PROVIDER: GSE103799 | GEO | 2017/09/14

SECONDARY ACCESSION(S): PRJNA407070

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
| S-EPMC5749515 | biostudies-literature
Unknown Antisense oligonucleotides offer hope to patients with Charcot-Marie-Tooth disease type 1A.
| S-EPMC5749496 | biostudies-literature
Unknown MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy.
| S-EPMC2832158 | biostudies-literature
Unknown Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease.
| S-EPMC2987248 | biostudies-literature
Unknown AAV-mediated editing of PMP22 rescues Charcot-Marie-Tooth disease type 1A features in patient-derived iPS Schwann cells.
| S-EPMC10684506 | biostudies-literature
Unknown Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A.
| S-EPMC8265963 | biostudies-literature
Unknown Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report.
| S-EPMC8740465 | biostudies-literature
Unknown Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
| S-EPMC7145652 | biostudies-literature
Unknown MicroRNAs as Biomarkers of Charcot-Marie-Tooth Disease Type 1A.
| S-EPMC8356381 | biostudies-literature
Transcriptomics Expression data from a Charcot-Marie-Tooth 1B neuropathy mouse model
2013-05-01 | E-GEOD-40610 | biostudies-arrayexpress